Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) EBT Margin (2016 - 2025)

Abeona Therapeutics (ABEO) has 13 years of EBT Margin data on record, last reported at 5937.25% in Q2 2025.

  • For Q2 2025, EBT Margin changed N/A year-over-year to 5937.25%; the TTM value through Sep 2025 reached 20646.5%, changed N/A, while the annual FY2023 figure was 1358.66%, 229417.0% up from the prior year.
  • EBT Margin reached 5937.25% in Q2 2025 per ABEO's latest filing, down from 304.49% in the prior quarter.
  • Across five years, EBT Margin topped out at 88054.72% in Q4 2021 and bottomed at 19285.29% in Q4 2022.
  • Average EBT Margin over 4 years is 6681.05%, with a median of 304.49% recorded in 2023.
  • Peak YoY movement for EBT Margin: soared 8879102bps in 2021, then plummeted -10734001bps in 2022.
  • A 4-year view of EBT Margin shows it stood at 88054.72% in 2021, then plummeted by -122bps to 19285.29% in 2022, then surged by 98bps to 304.49% in 2023, then plummeted by -1850bps to 5937.25% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 5937.25% in Q2 2025, 304.49% in Q2 2023, and 19285.29% in Q4 2022.